Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Nontuberculous lymphadenitis in children: What management strategy?

Gallois Y, Cogo H, Debuisson C, Guet-Revillet H, Brehin C, Baladi B, Calmels MN.

Int J Pediatr Otorhinolaryngol. 2019 Jul;122:196-202. doi: 10.1016/j.ijporl.2019.04.012. Epub 2019 Apr 14.

PMID:
31039497
2.

Association of the Duration of Antibiotic Therapy With Major Surgical Site Infection in Cochlear Implantation.

Sayed-Hassan A, Hermann R, Chidiac F, Truy E, Guevara N, Bailleux S, Deguine O, Baladi B, Gallois Y, Bozorg-Grayeli A, Lerosey Y, Godey B, Parietti-Winkler C, Pereira B, Mom T; and the Otolaryngology–Head and Neck Surgical Infection Survey Group (OSS Group) of Clermont-Ferrand.

JAMA Otolaryngol Head Neck Surg. 2019 Jan 1;145(1):14-20. doi: 10.1001/jamaoto.2018.1998.

PMID:
30325991
3.

Transnasal Endoscopic Sphenopalatine Artery Ligation Compared With Embolization for Intractable Epistaxis: A Long-term Analysis.

de Bonnecaze G, Gallois Y, Bonneville F, Vergez S, Chaput B, Serrano E.

Am J Rhinol Allergy. 2018 May;32(3):188-193. doi: 10.1177/1945892418768584. Epub 2018 Apr 20.

PMID:
29676168
4.

Intractable epistaxis: which arteries are responsible? An angiographic study.

de Bonnecaze G, Gallois Y, Chaynes P, Bonneville F, Dupret-Bories A, Chantalat E, Serrano E.

Surg Radiol Anat. 2017 Nov;39(11):1203-1207. doi: 10.1007/s00276-017-1856-5. Epub 2017 May 16.

PMID:
28508924
5.

Combination of blood tests for significant fibrosis and cirrhosis improves the assessment of liver-prognosis in chronic hepatitis C.

Boursier J, Brochard C, Bertrais S, Michalak S, Gallois Y, Fouchard-Hubert I, Oberti F, Rousselet MC, Calès P.

Aliment Pharmacol Ther. 2014 Jul;40(2):178-88. doi: 10.1111/apt.12813. Epub 2014 Jun 2.

6.

Precise evaluation of liver histology by computerized morphometry shows that steatosis influences liver stiffness measured by transient elastography in chronic hepatitis C.

Boursier J, de Ledinghen V, Sturm N, Amrani L, Bacq Y, Sandrini J, Le Bail B, Chaigneau J, Zarski JP, Gallois Y, Leroy V, Al Hamany Z, Oberti F, Fouchard-Hubert I, Dib N, Bertrais S, Rousselet MC, Calès P; Multicentre group ANRS HC EP23 FIBROSTAR.

J Gastroenterol. 2014 Mar;49(3):527-37. doi: 10.1007/s00535-013-0819-9. Epub 2013 May 17.

PMID:
23681425
7.

Determination of reliability criteria for liver stiffness evaluation by transient elastography.

Boursier J, Zarski JP, de Ledinghen V, Rousselet MC, Sturm N, Lebail B, Fouchard-Hubert I, Gallois Y, Oberti F, Bertrais S, Calès P; Multicentric Group from ANRS/HC/EP23 FIBROSTAR Studies.

Hepatology. 2013 Mar;57(3):1182-91. doi: 10.1002/hep.25993. Epub 2013 Feb 4.

PMID:
22899556
8.

Glucocorticoids reduce alveolar and trabecular bone in mice.

Bouvard B, Gallois Y, Legrand E, Audran M, Chappard D.

Joint Bone Spine. 2013 Jan;80(1):77-81. doi: 10.1016/j.jbspin.2012.01.009. Epub 2012 Feb 25.

9.

Comparison of accuracy of fibrosis degree classifications by liver biopsy and non-invasive tests in chronic hepatitis C.

Boursier J, Bertrais S, Oberti F, Gallois Y, Fouchard-Hubert I, Rousselet MC, Zarski JP, Calès P.

BMC Gastroenterol. 2011 Nov 30;11:132. doi: 10.1186/1471-230X-11-132.

10.

Steatosis degree, measured by morphometry, is linked to other liver lesions and metabolic syndrome components in patients with NAFLD.

Boursier J, Chaigneau J, Roullier V, Lainé F, Sandrini J, Michalak S, Hubert I, Dib N, Oberti F, Bertrais S, Hunault G, Deugnier Y, Rousselet MC, Cavaro-Ménard C, Gallois Y, Aubé C, Calès P; Study group UNAM-METABOL.

Eur J Gastroenterol Hepatol. 2011 Nov;23(11):974-81. doi: 10.1097/MEG.0b013e32834a4d82.

PMID:
21904208
11.

Comparison of eight diagnostic algorithms for liver fibrosis in hepatitis C: new algorithms are more precise and entirely noninvasive.

Boursier J, de Ledinghen V, Zarski JP, Fouchard-Hubert I, Gallois Y, Oberti F, Calès P; multicentric groups from SNIFF 32, VINDIAG 7, and ANRS/HC/EP23 FIBROSTAR studies.

Hepatology. 2012 Jan;55(1):58-67. doi: 10.1002/hep.24654.

PMID:
21898504
12.

A new combination of blood test and fibroscan for accurate non-invasive diagnosis of liver fibrosis stages in chronic hepatitis C.

Boursier J, de Ledinghen V, Zarski JP, Rousselet MC, Sturm N, Foucher J, Leroy V, Fouchard-Hubert I, Bertrais S, Gallois Y, Oberti F, Dib N, Calès P.

Am J Gastroenterol. 2011 Jul;106(7):1255-63. doi: 10.1038/ajg.2011.100. Epub 2011 Apr 5.

PMID:
21468012
13.

Human serum albumin improves endothelial dysfunction and survival during experimental endotoxemia: concentration-dependent properties.

Kremer H, Baron-Menguy C, Tesse A, Gallois Y, Mercat A, Henrion D, Andriantsitohaina R, Asfar P, Meziani F.

Crit Care Med. 2011 Jun;39(6):1414-22. doi: 10.1097/CCM.0b013e318211ff6e.

PMID:
21336119
14.

NT-ProBNP levels, water and sodium homeostasis in healthy men: effects of 7 days of dry immersion.

Navasiolava NM, Pajot A, Gallois Y, Pastushkova LKh, Kulchitsky VA, Gauquelin-Koch G, Kozlovskaya IB, Heer M, Hand O, Larina IM, Custaud MA.

Eur J Appl Physiol. 2011 Sep;111(9):2229-37. doi: 10.1007/s00421-011-1858-7. Epub 2011 Feb 16.

PMID:
21327795
15.

Assessment of new hyaluronic acid assays and their impact on FibroMeter scores.

Veillon P, Gallois Y, Moal V, Fouchard-Hubert I, Charles I, Larcher F, Dib N, Boursier J, Oberti F, Laafi J, Guéchot J, Balan V, Calès P, Lunel-Fabiani F.

Clin Chim Acta. 2011 Jan 30;412(3-4):347-52. doi: 10.1016/j.cca.2010.11.009. Epub 2010 Nov 12.

PMID:
21075099
16.

Bone status in a mouse model of genetic hemochromatosis.

Guggenbuhl P, Fergelot P, Doyard M, Libouban H, Roth MP, Gallois Y, Chalès G, Loréal O, Chappard D.

Osteoporos Int. 2011 Aug;22(8):2313-9. doi: 10.1007/s00198-010-1456-2. Epub 2010 Oct 26.

PMID:
20976594
17.

Optimization and robustness of blood tests for liver fibrosis and cirrhosis.

Calès P, Boursier J, Bertrais S, Oberti F, Gallois Y, Fouchard-Hubert I, Dib N, Zarski JP, Rousselet MC; multicentric groups (SNIFF 14 & 17, ANRS HC EP 23 Fibrostar).

Clin Biochem. 2010 Nov;43(16-17):1315-22. doi: 10.1016/j.clinbiochem.2010.08.010. Epub 2010 Aug 14.

PMID:
20713037
18.

Diagnosis of different liver fibrosis characteristics by blood tests in non-alcoholic fatty liver disease.

Calès P, Boursier J, Chaigneau J, Lainé F, Sandrini J, Michalak S, Hubert I, Dib N, Oberti F, Bertrais S, Hunault G, Cavaro-Ménard C, Gallois Y, Deugnier Y, Rousselet MC.

Liver Int. 2010 Oct;30(9):1346-54. doi: 10.1111/j.1478-3231.2010.02314.x.

PMID:
20666992
19.

Acoustic radiation force impulse: a new ultrasonographic technology for the widespread noninvasive diagnosis of liver fibrosis.

Boursier J, Isselin G, Fouchard-Hubert I, Oberti F, Dib N, Lebigot J, Bertrais S, Gallois Y, Calès P, Aubé C.

Eur J Gastroenterol Hepatol. 2010 Sep;22(9):1074-84. doi: 10.1097/MEG.0b013e328339e0a1.

PMID:
20440210
20.

Effect of alpha tocopherol acetate in Walker 256/B cells-induced oxidative damage in a rat model of breast cancer skeletal metastases.

Badraoui R, Blouin S, Moreau MF, Gallois Y, Rebai T, Sahnoun Z, Baslé M, Chappard D.

Chem Biol Interact. 2009 Dec 10;182(2-3):98-105. doi: 10.1016/j.cbi.2009.09.010. Epub 2009 Sep 23.

PMID:
19781538
21.

The combination of a blood test and Fibroscan improves the non-invasive diagnosis of liver fibrosis.

Boursier J, Vergniol J, Sawadogo A, Dakka T, Michalak S, Gallois Y, Le Tallec V, Oberti F, Fouchard-Hubert I, Dib N, Rousselet MC, Konaté A, Amrani N, de Ledinghen V, Calès P.

Liver Int. 2009 Nov;29(10):1507-15. doi: 10.1111/j.1478-3231.2009.02101.x. Epub 2009 Sep 2.

PMID:
19725892
22.

Hemodynamic effects of the early and long-term administration of propranolol in rats with intrahepatic portal hypertension.

Fizanne L, Régenet N, Wang J, Oberti F, Moal F, Roux J, Gallois Y, Michalak S, Calès P.

Hepatol Int. 2008 Dec;2(4):457-64. doi: 10.1007/s12072-008-9070-5. Epub 2008 Apr 12.

23.

Genetic variant in HK1 is associated with a proanemic state and A1C but not other glycemic control-related traits.

Bonnefond A, Vaxillaire M, Labrune Y, Lecoeur C, Chèvre JC, Bouatia-Naji N, Cauchi S, Balkau B, Marre M, Tichet J, Riveline JP, Hadjadj S, Gallois Y, Czernichow S, Hercberg S, Kaakinen M, Wiesner S, Charpentier G, Lévy-Marchal C, Elliott P, Jarvelin MR, Horber F, Dina C, Pedersen O, Sladek R, Meyre D, Froguel P.

Diabetes. 2009 Nov;58(11):2687-97. doi: 10.2337/db09-0652. Epub 2009 Aug 3.

24.

FibroMeters: a family of blood tests for liver fibrosis.

Calès P, Boursier J, Oberti F, Hubert I, Gallois Y, Rousselet MC, Dib N, Moal V, Macchi L, Chevailler A, Michalak S, Hunault G, Chaigneau J, Sawadogo A, Lunel F.

Gastroenterol Clin Biol. 2008 Sep;32(6 Suppl 1):40-51. doi: 10.1016/S0399-8320(08)73992-7.

25.

[FibroMeters: a family of blood tests for liver fibrosis with high diagnostic performance and applicability in clinical practice].

Calès P, Boursier J, Oberti F, Gallois Y, Rousselet MC, Moal V, Macchi L, Chevailler A, Lunel F.

Pathol Biol (Paris). 2009 Sep;57(6):459-62. doi: 10.1016/j.patbio.2008.09.009. Epub 2008 Dec 2. French. No abstract available.

PMID:
19054629
26.

Fatty liver and insulin resistance in obese Zucker rats: no role for mitochondrial dysfunction.

Flamment M, Arvier M, Gallois Y, Simard G, Malthièry Y, Ritz P, Ducluzeau PH.

Biochimie. 2008 Sep;90(9):1407-13. doi: 10.1016/j.biochi.2008.05.003. Epub 2008 May 15.

PMID:
18534199
27.

Prognostic value of the insertion/deletion polymorphism of the ACE gene in type 2 diabetic subjects: results from the Non-insulin-dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR), Diabete de type 2, Nephropathie et Genetique (DIAB2NEPHROGENE), and Survie, Diabete de type 2 et Genetique (SURDIAGENE) studies.

Hadjadj S, Fumeron F, Roussel R, Saulnier PJ, Gallois Y, Ankotche A, Travert F, Abi Khalil C, Miot A, Alhenc-Gelas F, Lievre M, Marre M; DIABHYCAR Study Group; DIAB2NEPHROGENE Study Group; SURDIAGENE Study Group.

Diabetes Care. 2008 Sep;31(9):1847-52. doi: 10.2337/dc07-2079. Epub 2008 Jun 3.

28.

Distribution of adipose tissue: quantification and relationship with hepatic steatosis and vascular profiles of type 2 diabetic patients with metabolic syndrome.

Illouz F, Roulier V, Rod A, Gallois Y, Pellé CP, Aubé C, Rohmer V, Ritz P, Ducluzeau PH.

Diabetes Metab. 2008 Feb;34(1):68-74. doi: 10.1016/j.diabet.2007.10.007. Epub 2008 Feb 1.

PMID:
18243026
29.

Osteopontin is histochemically detected by the AgNOR acid-silver staining.

Gaudin-Audrain C, Gallois Y, Pascaretti-Grizon F, Hubert L, Massin P, Baslé MF, Chappard D.

Histol Histopathol. 2008 Apr;23(4):469-78. doi: 10.14670/HH-23.469.

30.

Osteopontin is an argentophilic protein in the bone matrix and in cells of kidney convoluted tubules.

Pascaretti-Grizon F, Gaudin-Audrain C, Gallois Y, Retaillaud-Gaborit N, Baslé MF, Chappard D.

Morphologie. 2007 Oct;91(294):180-5. Epub 2007 Nov 26.

PMID:
18036861
31.

Reproducibility of blood tests of liver fibrosis in clinical practice.

Calès P, Veillon P, Konaté A, Mathieu E, Ternisien C, Chevailler A, Godon A, Gallois Y, Joubaud F, Hubert-Fouchard I, Oberti F, Réaud S, Hunault G, Mauriat F, Lunel-Fabiani F.

Clin Biochem. 2008 Jan;41(1-2):10-8. Epub 2007 Aug 24.

PMID:
17988658
32.

Low serum testosterone assayed by liquid chromatography-tandem mass spectrometry. Comparison with five immunoassay techniques.

Moal V, Mathieu E, Reynier P, Malthièry Y, Gallois Y.

Clin Chim Acta. 2007 Nov-Dec;386(1-2):12-9. Epub 2007 Jul 19.

PMID:
17706625
33.

Diagnosis and measurement of liver fibrosis by MRI in bile duct ligated rats.

Aubé C, Moal F, Oberti F, Roux J, Croquet V, Gallois Y, Argaud C, Caron C, Calès P.

Dig Dis Sci. 2007 Oct;52(10):2601-9. Epub 2007 Apr 11.

PMID:
17429735
34.

Efficacy of indapamide SR compared with enalapril in elderly hypertensive patients with type 2 diabetes.

Puig JG, Marre M, Kokot F, Fernandez M, Jermendy G, Opie L, Moyseev V, Scheen A, Ionescu-Tirgoviste C, Saldanha MH, Halabe A, Williams B, Mion D Jr, Ruiz M, Hermansen K, Tuomilehto J, Finizola B, Gallois Y, Amouyel P, Ollivier JP, Asmar R.

Am J Hypertens. 2007 Jan;20(1):90-7.

35.

Hemodynamic and antifibrotic effects of a selective liver nitric oxide donor V-PYRRO/NO in bile duct ligated rats.

Moal F, Veal N, Vuillemin E, Barrière E, Wang J, Fizanne L, Oberti F, Douay O, Gallois Y, Bonnefont-Rousselot D, Rousselet MC, Calès P.

World J Gastroenterol. 2006 Nov 7;12(41):6639-45.

36.

Disuse and orchidectomy have additional effects on bone loss in the aged male rat.

Blouin S, Gallois Y, Moreau MF, Baslé MF, Chappard D.

Osteoporos Int. 2007 Jan;18(1):85-92. Epub 2006 Sep 26.

PMID:
17019521
37.

Absence of renal lesions in C57BL/KaLwRij mice with advanced myeloma due to 5T2MM cells.

Libouban H, Onno C, Pascaretti-Grizon F, Gallois Y, Moreau MF, Baslé MF, Chappard D.

Leuk Res. 2006 Nov;30(11):1371-5. Epub 2006 Jun 30.

PMID:
16814861
38.

Medullar fat influences texture analysis of trabecular microarchitecture on X-ray radiographs.

Chappard D, Pascaretti-Grizon F, Gallois Y, Mercier P, Baslé MF, Audran M.

Eur J Radiol. 2006 Jun;58(3):404-10. Epub 2006 Jan 26.

PMID:
16443344
39.

A novel panel of blood markers to assess the degree of liver fibrosis.

Calès P, Oberti F, Michalak S, Hubert-Fouchard I, Rousselet MC, Konaté A, Gallois Y, Ternisien C, Chevailler A, Lunel F.

Hepatology. 2005 Dec;42(6):1373-81.

PMID:
16317693
40.

Modulation of the renal response to ACE inhibition by ACE insertion/deletion polymorphism during hyperglycemia in normotensive, normoalbuminuric type 1 diabetic patients.

Weekers L, Bouhanick B, Hadjadj S, Gallois Y, Roussel R, Pean F, Ankotche A, Chatellier G, Alhenc-Gelas F, Lefebvre PJ, Marre M.

Diabetes. 2005 Oct;54(10):2961-7.

41.

Early vasodilator response to anodal current application in human is not impaired by cyclooxygenase-2 blockade.

Tartas M, Bouyé P, Koïtka A, Durand S, Gallois Y, Saumet JL, Abraham P.

Am J Physiol Heart Circ Physiol. 2005 Apr;288(4):H1668-73. Epub 2004 Nov 24.

42.

Different patterns of insulin resistance in relatives of type 1 diabetic patients with retinopathy or nephropathy: the Genesis France-Belgium Study.

Hadjadj S, Péan F, Gallois Y, Passa P, Aubert R, Weekers L, Rigalleau V, Bauduceau B, Bekherraz A, Roussel R, Dussol B, Rodier M, Marechaud R, Lefebvre PJ, Marre M; Genesis France-Belgium Study.

Diabetes Care. 2004 Nov;27(11):2661-8.

PMID:
15505002
43.

Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with type 2 diabetes: the NESTOR Study.

Marre M, Puig JG, Kokot F, Fernandez M, Jermendy G, Opie L, Moyseev V, Scheen A, Ionescu-Tirgoviste C, Saldanha MH, Halabe A, Williams B, Mion Júnior D, Ruiz M, Hermansen K, Tuomilehto J, Finizola B, Gallois Y, Amouyel P, Ollivier JP, Asmar R.

J Hypertens. 2004 Aug;22(8):1613-22.

44.

Ex vivo bone mineral density of the wrist: influence of medullar fat.

Chappard D, Moquereau M, Mercier P, Gallois Y, Legrand E, Baslé MF, Audran M.

Bone. 2004 Jun;34(6):1023-8.

PMID:
15193549
45.

Serum triglycerides are a predictive factor for the development and the progression of renal and retinal complications in patients with type 1 diabetes.

Hadjadj S, Duly-Bouhanick B, Bekherraz A, BrIdoux F, Gallois Y, Mauco G, Ebran J, Marre M.

Diabetes Metab. 2004 Feb;30(1):43-51.

PMID:
15029097
46.

Respective roles of porto-septal fibrosis and centrilobular fibrosis in alcoholic liver disease.

Michalak S, Rousselet MC, Bedossa P, Pilette C, Chappard D, Oberti F, Gallois Y, Calès P.

J Pathol. 2003 Sep;201(1):55-62.

PMID:
12950017
47.

Angiotensin-I-converting enzyme insertion/deletion polymorphism and high urinary albumin concentration in French Type 2 diabetes patients.

Hadjadj S, Gallois Y, Alhenc-Gelas F, Chatellier G, Marre M, Genes N, Lievre M, Mann J, Menard J, Vasmant D; DIABHYCAR Study Group.

Diabet Med. 2003 Aug;20(8):677-82.

PMID:
12873298
48.

Vasopressin increases urinary albumin excretion in rats and humans: involvement of V2 receptors and the renin-angiotensin system.

Bardoux P, Bichet DG, Martin H, Gallois Y, Marre M, Arthus MF, Lonergan M, Ruel N, Bouby N, Bankir L.

Nephrol Dial Transplant. 2003 Mar;18(3):497-506.

PMID:
12584270
49.

Low-dose terlipressin improves systemic and splanchnic hemodynamics in fluid-challenged endotoxic rats.

Asfar P, Pierrot M, Veal N, Moal F, Oberti F, Croquet V, Douay O, Gallois Y, Saumet JL, Alquier P, Calès P.

Crit Care Med. 2003 Jan;31(1):215-20.

PMID:
12545018
50.

Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis and/or portal hypertension.

Croquet V, Moal F, Veal N, Wang J, Oberti F, Roux J, Vuillemin E, Gallois Y, Douay O, Chappard D, Calès P.

J Hepatol. 2002 Dec;37(6):773-80.

PMID:
12445418

Supplemental Content

Loading ...
Support Center